brain neoplasm: A neoplasm (disease) that involves the brain.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
227 |
4. Check minimum number of eventsNone |
227 |
5. Include endpointsNone |
227 |
6. Filter based on genotype QC (FinnGen only) |
220 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D31
- Name in latin
- Neoplasma benignum orbitae non specificatum
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Orbit, unspecified
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of eye and adnexa
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1703 | 988 | 701 |
| Only index persons | 1480 | 873 | 607 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.03 | 0.02 |
| Only index persons | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 50.29 | 50.56 | 49.71 |
| Only index persons | 49.65 | 50.35 | 48.65 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 220 | 145 | 75 |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | 0.03 |
| Median age at first event (years) | 54.78 | 52.92 | 58.38 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 227
- Matched controls
- 2270
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
+∞
262.3
198
*
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
286.7
46.9
46
*
CAA30
NOMESCO Finland
Biopsy of orbit
+∞
36.4
34
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.1
23.8
47
93
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
9.0
20.0
26
32
CAB00
NOMESCO Finland
Anterior orbitotomy with excision of lesion
+∞
19.0
18
*
H05.2
ICD-10 Finland
Exophthalmic conditions
109.2
18.9
20
*
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
+∞
17.9
17
*
22405
ICD-8 Finland
Benign neoplasm of eye, Orbitae
+∞
16.9
16
*
2241A
ICD-9 Finland
Benign neoplasm of eye, Orbit
+∞
16.9
16
*
XCK00
NOMESCO Finland
Perimetry
5.1
14.8
34
76
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.3
14.4
68
257
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
45.7
14.3
17
*
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
36.5
13.7
17
5
CA1DG
NOMESCO Finland
Eye and orbita very extensive MRI examination with high intensity magnet
+∞
12.6
12
*
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
4.7
11.9
29
68
CAB10
NOMESCO Finland
Lateral orbitotomy with excision of lesion
+∞
11.6
11
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.6
11.4
125
726
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
16.6
11.0
17
11
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
8.1
10.5
23
31
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
27.4
9.9
13
5
XCK10
NOMESCO Finland
Photography of fundus of eye
3.5
9.9
38
124
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
9.9
123
742
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
104.2
9.5
10
*
H05.9
ICD-10 Finland
Disorder of orbit, unspecified
+∞
9.4
9
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.4
9.4
104
592
H57.1
ICD-10 Finland
Ocular pain
4.9
9.3
21
46
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
14.8
8.8
14
10
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
17.1
8.7
13
8
H04.10
ICD-10 Finland
Dry eye syndrome
3.0
8.5
41
154
CS494
NOMESCO Finland
Other visual field testing
7.6
8.5
19
27
H05.1
ICD-10 Finland
Chronic inflammatory disorders of orbit
+∞
8.4
8
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
8.3
74
379
WX002
NOMESCO Finland
Sedation and analgesia
2.5
8.1
59
275
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
7.9
97
567
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.6
7.6
50
221
C69.60
ICD-10 Finland
Malignant tumor in orbit without histology
82.7
7.5
8
*
AA1AD
NOMESCO Finland
CT of head and brain
2.3
7.3
79
435
9699/3-C69.6
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of orbit, NOS
+∞
7.3
7
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.0
7.1
34
126
D36.1
ICD-10 Finland
Benign neoplasm: Peripheral nerves and autonomic nervous system
23.3
6.7
9
*
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
12.8
6.7
11
9
ZXA05
NOMESCO Finland
Left side
2.2
6.5
68
368
D31.5
ICD-10 Finland
Benign neoplasm: Lacrimal gland and duct
+∞
6.3
6
*
CAW99
NOMESCO Finland
Other operation on orbit
+∞
6.3
6
*
C69.63
ICD-10 Finland
Malignant tumor of orbital carcinoma
+∞
6.3
6
*
WX110
NOMESCO Finland
Infiltration anesthesia
2.2
6.2
170
1306
CBA10
NOMESCO Finland
Biopsy of eyelid
13.0
6.1
10
8
XCD10
NOMESCO Finland
Electrophysiological examination of eye
6.3
6.1
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
150
1078
2.15
6.87
8.3
8.8
4.20
4.08
e9/l
0.23
125
961
121
814
2.04
6.48
5.5
6.2
1.21
1.22
mmol/l
0.62
112
742
43
190
2.56
6.47
3.8
4.4
215.07
245.90
u/l
2.15
43
176
215
1884
3.67
5.18
16.0
14.0
21.77
22.73
mg/l
0.15
186
1471
119
845
1.86
4.99
15.0
13.9
1.29
1.22
inr
0.24
23
259
123
887
1.84
4.87
6.9
7.1
1.21
1.21
mmol/l
0.17
108
752
171
1386
1.95
4.50
3.9
3.9
12.23
11.61
mm/h
0.25
160
1262
123
929
1.71
3.82
6.3
5.3
0.00
0.00
estimate
-0.00
16
186
122
921
1.70
3.78
4.8
4.0
0.00
0.01
estimate
0.50
16
199
124
942
1.70
3.74
4.9
4.0
0.00
0.00
estimate
-0.00
16
183
104
756
1.69
3.68
2.1
1.9
93.89
95.85
pmol/l
0.17
54
369
198
1733
2.12
3.58
5.6
4.7
1.74
1.90
mu/l
1.47
183
1573
69
453
1.75
3.50
1.5
1.5
23.56
21.85
nmol/l
0.36
62
376
169
1425
1.73
3.20
4.7
4.0
14.68
14.79
pmol/l
0.24
157
1274
198
1755
2.00
3.12
14.1
13.4
83.45
81.59
ml/min/173m2
0.52
158
1427
51
319
1.77
3.02
3.6
2.5
0.47
1.10
e6/l
1.81
21
185
211
1920
2.40
3.02
18.8
16.4
139.52
139.68
mmol/l
0.47
211
1864
29
150
2.07
3.01
2.9
2.4
68.92
63.19
ml/min/173m2
0.35
12
67
65
438
1.68
2.95
2.0
2.3
—
—
—
0
0
151
1252
1.62
2.89
6.5
4.8
—
2794.08
—
0
24
103
783
1.58
2.85
5.6
4.6
36.12
35.79
g/l
0.28
93
735
11
34
3.35
2.76
1.2
1.2
2.17
4.44
u/ml
—
6
16
7
15
4.78
2.61
1.0
1.1
—
—
—
0
0
36
212
1.83
2.59
7.3
9.9
0.49
1.29
mmol/l
1.46
29
173
13
50
2.70
2.58
2.2
2.3
—
—
—
0
0
7
16
4.48
2.49
1.3
1.0
—
—
—
0
0
220
2084
2.80
2.41
25.3
20.4
39.80
40.06
%
0.26
214
1959
214
1988
2.34
2.39
11.3
10.1
23.79
25.25
u/l
1.06
208
1914
6
13
4.71
2.28
1.7
1.8
—
—
—
0
0
220
2088
2.74
2.28
24.9
20.4
133.47
134.58
g/l
0.57
220
2055
46
302
1.66
2.27
3.5
2.7
4.90
2.78
e6/l
0.29
16
169
220
2086
2.77
2.27
24.9
20.3
4.45
4.47
e12/l
0.20
213
2027
59
413
1.58
2.25
2.4
1.8
1.40
1.20
mg/l
0.16
46
319
166
1445
1.55
2.25
7.6
7.2
74.56
76.78
u/l
0.37
160
1354
110
881
1.48
2.24
2.4
2.6
—
—
—
0
0
37
230
1.73
2.23
7.0
6.7
105.59
104.09
mmol/l
1.38
37
230
5
9
5.65
2.22
1.0
1.6
—
—
—
0
0
72
529
1.53
2.22
3.4
2.9
0.35
0.56
e6/l
0.59
44
397
51
352
1.58
2.06
4.7
3.8
21.53
262.21
ng/l
1.79
36
285
82
629
1.48
2.03
4.0
3.3
2.34
2.35
mmol/l
0.48
73
549
13
57
2.36
2.02
2.0
1.5
—
—
—
0
0
20
106
1.97
1.98
1.8
1.7
—
—
—
0
0
5
11
4.62
1.95
1.2
1.0
—
—
—
0
0
7
23
3.11
1.81
2.3
2.0
—
—
—
0
0
144
1248
1.42
1.76
2.8
3.2
35.84
45.63
u/l
1.76
134
1170
119
998
1.40
1.75
6.3
6.2
10.71
10.60
umol/l
0.05
114
940
180
1633
1.49
1.66
18.9
16.8
14.49
14.83
%
0.42
180
1606
86
688
1.40
1.64
3.7
2.9
—
—
—
0
0
20
114
1.83
1.62
2.6
2.4
9.41
13.17
nmol/l
1.09
15
106
190
1746
1.54
1.61
4.0
4.0
1.30
1.26
mmol/l
0.34
169
1598
8
32
2.55
1.61
1.0
1.2
—
—
—
0
0
197
1826
1.60
1.59
4.5
4.4
5.87
5.91
mmol/l
0.20
177
1666
197
1828
1.59
1.56
4.5
4.4
4.68
4.68
mmol/l
0.03
184
1689
5
15
3.38
1.53
1.0
1.1
—
—
—
0
0
30
196
1.61
1.53
2.1
1.8
—
—
—
0
0
200
1866
1.60
1.50
5.2
4.9
2.76
2.76
mmol/l
0.01
187
1711
9
38
2.42
1.47
1.6
1.3
—
—
—
0
0
88
718
1.37
1.47
3.9
3.8
20.08
43.55
ng/l
2.12
63
500
6
22
2.77
1.44
1.0
1.2
—
—
—
0
0
30
199
1.58
1.44
2.1
1.9
—
—
—
0
0
9
40
2.30
1.42
1.0
1.3
—
47.08
—
0
6
195
1816
1.52
1.40
4.5
4.4
1.46
1.50
mmol/l
0.47
178
1672
9
41
2.24
1.38
1.3
1.3
—
—
—
0
0
9
41
2.24
1.38
1.3
1.3
—
—
—
0
0
6
23
2.65
1.37
1.0
1.2
—
—
—
0
0
13
69
1.94
1.31
2.8
2.0
3.08
2.76
g/l
0.48
13
62
69
552
1.36
1.28
3.3
3.3
1136.76
1474.07
ng/l
0.44
56
463
8
35
2.33
1.28
1.3
1.1
—
—
—
0
0
13
70
1.91
1.26
2.8
2.0
10.13
9.54
g/l
0.25
13
62
40
293
1.44
1.23
1.8
1.9
—
—
—
0
0
5
19
2.67
1.22
1.0
1.1
—
—
—
0
0
39
285
1.44
1.21
2.6
3.4
0.82
0.82
mmol/l
0.11
34
264
46
347
1.41
1.21
1.5
1.5
—
—
—
0
0
185
1720
1.41
1.19
5.8
5.7
39.16
39.74
mmol/mol
0.44
173
1602
41
304
1.43
1.18
1.2
1.2
12.32
37.79
iu/ml
2.63
11
92
8
39
2.09
1.16
1.1
1.3
—
1.04
—
0
5
8
39
2.09
1.16
1.1
1.2
3.30
3.84
mmol/l
—
8
34
12
65
1.89
1.16
3.2
2.4
1150.92
8556.75
u/l
—
6
20
31
219
1.48
1.15
10.0
7.0
—
—
—
0
0
8
40
2.04
1.13
1.3
1.3
—
—
—
0
0
10
51
2.01
1.13
3.5
5.1
48.11
24.57
mg/l
—
10
40
10
51
2.01
1.13
1.6
1.2
—
—
—
0
0
10
51
2.01
1.13
3.5
5.1
73.29
70.09
mg/l
—
10
40
27
187
1.50
1.10
3.8
3.9
2.28
42.22
ug/l
0.58
19
157
20
129
1.60
1.10
1.5
1.6
—
—
—
0
0
13
75
1.78
1.05
2.8
1.9
3.48
3.40
g/l
0.11
13
68
13
75
1.78
1.05
2.8
1.9
—
—
—
0
0
13
75
1.78
1.05
2.8
1.9
7.65
7.43
g/l
0.16
13
68
11
60
1.88
1.04
1.5
2.1
37.66
39.51
g/l
0.50
11
53
29
207
1.46
1.03
2.0
1.9
—
—
—
0
0
132
1186
1.27
0.99
3.4
3.1
—
—
—
0
0
39
297
1.38
0.98
1.2
1.2
1.18
11.08
u/ml
2.33
12
112
16
101
1.63
0.96
5.2
5.6
24.99
24.75
mmol/l
0.15
16
101
16
102
1.61
0.93
1.1
1.2
50.70
218.12
u/ml
2.70
16
92
33
247
1.39
0.92
3.1
2.3
21.81
22.64
%
0.13
28
207
94
817
1.26
0.91
3.3
2.6
94.87
108.35
ug/l
0.57
89
742
8
45
1.81
0.85
1.0
1.4
—
—
—
0
0
6
31
1.96
0.85
1.2
1.3
—
—
—
0
0
56
461
1.29
0.84
2.8
2.0
2.88
2.99
mg/l
0.18
45
392
43
344
1.31
0.80
1.6
1.6
1142.72
1200.78
nmol/l
0.16
33
254
31
236
1.36
0.79
2.3
2.0
—
—
—
0
0
11
171
0.63
0.75
1.9
1.7
—
—
—
0
0
30
230
1.35
0.74
4.2
4.4
30.63
31.75
%
0.25
19
151
7
39
1.82
0.73
1.0
1.4
—
—
—
0
0
44
359
1.28
0.71
3.7
2.6
2.45
2.45
mmol/l
0.04
37
311
5
27
1.87
0.69
1.0
1.5
—
—
—
0
0
88
784
1.20
0.64
1.9
2.2
75.48
76.53
nmol/l
0.13
74
689
13
88
1.51
0.62
2.5
2.3
0.74
0.66
%
0.39
13
88
8
54
1.50
0.58
1.5
1.2
—
—
—
0
0
6
37
1.64
0.56
1.3
1.8
—
—
—
0
0
13
91
1.45
0.54
2.5
2.3
1.18
1.15
%
0.05
13
91
14
100
1.43
0.53
1.1
1.3
—
—
—
0
0
9
64
1.42
0.52
1.4
1.9
1075.89
349.92
ug/l
—
9
58
35
292
1.23
0.49
2.7
3.1
0.99
0.78
ug/l
0.45
22
192
7
46
1.54
0.48
1.0
1.4
—
—
—
0
0
7
49
1.44
0.46
1.0
1.1
—
—
—
0
0
61
541
1.17
0.46
3.9
3.7
10.53
11.20
mg/mmol
0.04
34
341
81
737
1.15
0.44
5.6
4.1
—
—
—
0
0
45
390
1.19
0.44
1.4
1.7
407.16
453.92
pmol/l
0.59
37
319
8
59
1.37
0.41
1.1
1.8
—
—
—
0
0
0
15
0.00
0.41
0.0
2.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
8
60
1.35
0.40
1.3
1.4
—
—
—
0
0
5
36
1.40
0.38
1.0
1.3
—
—
—
0
0
6
41
1.48
0.36
1.2
2.0
—
—
—
0
0
6
46
1.31
0.33
1.2
1.5
—
—
—
0
0
14
110
1.29
0.32
1.3
1.3
—
—
—
0
0
7
53
1.33
0.31
1.0
1.2
—
—
—
0
0
7
54
1.31
0.30
1.0
1.2
—
—
—
0
0
7
54
1.31
0.30
1.0
1.2
—
—
—
0
0
44
394
1.14
0.30
3.3
4.4
22.91
20.66
%
0.27
16
185
8
64
1.26
0.28
1.4
2.1
—
—
—
0
0
13
106
1.24
0.23
2.2
1.7
—
—
—
0
0
5
41
1.22
0.22
1.2
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
10
0.00
0.21
0.0
2.0
—
50.50
—
0
10
0
12
0.00
0.21
0.0
3.1
—
—
—
0
0
0
12
0.00
0.21
0.0
3.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.8
—
13.62
—
0
13
0
14
0.00
0.20
0.0
3.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
6
51
1.18
0.19
2.0
1.9
—
—
—
0
0
24
213
1.14
0.19
1.3
1.6
1.34
1.47
%
0.42
19
188
6
77
0.77
0.16
6.0
1.8
1.35
3.89
mg/l
—
6
55
9
105
0.85
0.13
1.0
1.0
—
—
—
0
0
5
60
0.83
0.08
1.4
1.4
—
—
—
0
0
5
60
0.83
0.08
1.4
1.4
—
—
—
0
0
5
60
0.83
0.08
1.4
1.4
—
—
—
0
0
31
327
0.94
0.08
1.4
1.4
—
—
—
0
0
8
74
1.08
0.07
1.4
2.0
—
—
—
0
0
8
76
1.05
0.07
1.3
2.1
—
—
—
0
0
53
516
1.04
0.05
7.3
4.3
0.00
0.00
estimate
-0.00
16
183
43
417
1.04
0.04
1.3
1.3
1.00
0.97
u/ml
—
7
108
10
108
0.92
0.03
1.5
1.5
—
—
—
0
0
14
132
1.06
0.02
2.7
1.8
—
—
—
0
0
20
192
1.05
0.02
2.0
3.4
—
—
—
0
0
51
519
0.98
0.02
1.7
1.6
1.30
1.32
mmol/l
0.07
45
433
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
4.4
—
103.75
—
0
8
0
8
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
7.29
—
0
7
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
87.60
—
0
5
0
9
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
10.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
7
69
1.01
-0.00
1.4
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_ORBIT_NOS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_ORBIT_NOS | 1.274 [1.0, 1.63] | 0.051 |
| Birth year | 0.99 [0.98, 1.0] | 0.051 |
During the follow-up period (1.1.1998 — 31.12.2019), 108 out of 648 females with CD2_BENIGN_ORBIT_NOS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_ORBIT_NOS | 1.337 [1.0, 1.79] | 0.053 |
| Birth year | 0.984 [0.97, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 90 out of 444 males with CD2_BENIGN_ORBIT_NOS died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_ORBIT_NOS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.107% | 0.224% |
| 5 | 0.624% | 1.468% |
| 10 | 1.459% | 3.587% |
| 15 | 2.954% | 6.69% |
| 20 | 5.353% | 11.526% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_ORBIT_NOS – Benign neoplasm: Orbit, unspecified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data